6 Third Avenue Management Collegium Pharmaceutical Trades
Third Avenue Management acquired 155k Collegium Pharmaceutical shares worth $5.18M. That's 0.81% of their equity portfolio (38th largest holding). Third Avenue Management started to build up the position in Collegium Pharmaceutical in Q4 2023 and continued to invest until Q4 2024. Since then they sold 48.3k shares. The stake costed the investor $4.75M, netting the investor a gain of 9.1% so far.
News about Collegium Pharmaceutical Inc and Third Avenue Management
Brandywine Global Investment Management LLC Boosts Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
… Selling at Collegium Pharmaceutical In other Collegium Pharmaceutical news, EVP … stock. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceu...
Mutual of America Capital Management LLC Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)
… year. Collegium Pharmaceutical Profile (Free Report) Collegium Pharmaceutical , Inc, a … specialty pharmaceutical company, develops and … 39; ratings for C...